Latest Articles
MEIS1-mediated Apoptosis via TNFR1 in Endometriosis.
Abnormal apoptosis both maintains endometrial cell growth and induces endometrial pathogenesis. The etiology of endometriosis is unclear and no treatment is curative. Therefore, the aim herein was to identify genes …
Published: Feb. 11, 2025, midnight
ACR-368 OncoSignature Assay Receives FDA Breakthrough Device Designation for Endometrial Cancer - Pharmacy Times
ACR-368 OncoSignature Assay Receives FDA Breakthrough Device Designation for Endometrial Cancer Pharmacy Times
Published: Feb. 10, 2025, 2:34 p.m.
SMARCA4-deficient Undifferentiated Carcinoma Co-existing with Primary Endometrial Gastric (or Gastrointestinal) -Type Carcinoma：A Case Report - Frontiers
SMARCA4-deficient Undifferentiated Carcinoma Co-existing with Primary Endometrial Gastric (or Gastrointestinal) -Type Carcinoma：A Case Report Frontiers
Published: Feb. 10, 2025, 2:08 p.m.
FDA Grants Breakthrough Status to Endometrial Cancer Assay - www.oncnursingnews.com/
FDA Grants Breakthrough Status to Endometrial Cancer Assay www.oncnursingnews.com/
Published: Feb. 9, 2025, 3:01 p.m.
Inhibition of lanosterol synthase linking with MAPK/JNK signaling pathway suppresses endometrial cancer - Nature.com
Inhibition of lanosterol synthase linking with MAPK/JNK signaling pathway suppresses endometrial cancer Nature.com
Published: Feb. 8, 2025, 1:17 p.m.
Molecular characterization of mixed-histology endometrial carcinoma provides prognostic and therapeutic value over morphologic findings - Nature.com
Molecular characterization of mixed-histology endometrial carcinoma provides prognostic and therapeutic value over morphologic findings Nature.com
Published: Feb. 8, 2025, 11:59 a.m.
Long-term risk of endometrial cancer after assisted reproductive technology.
What is the risk of endometrial cancer after long-term follow-up in women treated with ART between 1983 and 2001 compared with women in the general population and subfertile women who …
Published: Feb. 7, 2025, midnight
GLP1R Modulates Ferroptosis and Promotes Endometrial Cancer Progression: Insights from AN3CA Cell Study - Medical Dialogues
GLP1R Modulates Ferroptosis and Promotes Endometrial Cancer Progression: Insights from AN3CA Cell Study Medical Dialogues
Published: Feb. 6, 2025, 2:45 p.m.
FDA grants breakthrough designation for Acrivon’s endometrial cancer assay - Medical Device Network
FDA grants breakthrough designation for Acrivon’s endometrial cancer assay Medical Device Network
Published: Feb. 6, 2025, 10 a.m.
FDA grants breakthrough designation for Acrivon’s endometrial cancer assay - Yahoo! Voices
FDA grants breakthrough designation for Acrivon’s endometrial cancer assay Yahoo! Voices
Published: Feb. 6, 2025, 9:54 a.m.
Link copied to clipboard!